IL-2 and Mycobacterial Lipoarabinomannan as Targets of Immune Responses in Multiple Sclerosis Patients

Interleukin 2 (IL-2) is considered a key player in exacerbating multiple sclerosis (MS). Therapies targeting its receptor have been developed; however, a resolution of the disease and side effects are still an issue of concern. The involvement of other factors, such as Mycobacterium avium subspecies...

Descripción completa

Detalles Bibliográficos
Autores principales: Bo, Marco, Niegowska, Magdalena, Frau, Jessica, Sechi, GianPietro, Arru, Giannina, Cocco, Eleonora, Sechi, Leonardo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232413/
https://www.ncbi.nlm.nih.gov/pubmed/32244639
http://dx.doi.org/10.3390/microorganisms8040500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232413/
https://www.ncbi.nlm.nih.gov/pubmed/32244639
http://dx.doi.org/10.3390/microorganisms8040500

Ejemplares similares